Elevated levels of MDM2 have been correlated with poor prognosis in several cancer types, including solid tumors of the lung, esophagus, breast, stomach, as well as liposarcomas, glioblastomas, and leukemias (Yao et al., 2024[256]). This evidence concerns the gene MDM2 and leukemia.